Page not found

Integrative Physiology & Pharmacology Ph.D. Program at Wake Forest University


Wake Forest University Graduate School » Integrative Physiology & Pharmacology Ph.D. Program

Richard Weinberg, M.D.

Richard Weinberg, M.D.
Clinical Specialties
Gastroenterology , Diarrhea , Small Intestinal Disorders , Nutrition
Education & Training
  AB Harvard University 1971
  MD Johns Hopkins University School of Medicine 1975
Residency Internal Medicine U Chicago Hosps & Clinics 1978
Internship Internal Medicine U Chicago Hosps & Clinics 1976
Fellowship   U Chicago Hosps & Clinics 1981
Board Certifications
American Board of Internal Medicine , Internal Medicine
American Board of Internal Medicine , Internal Medicine , Gastroenterology
Memberships
American Association for the Advancement of Science
American Gastroenterological Association
American Heart Association
American Instit of Nutrition

 

Benson PW, Hooker JB, Koch KL, Weinberg RB. Bitter taster status predicts susceptibility to vection-induced motion sickness and nausea. Neurogastroenterol Motil. 2012;24(2):134-40,e86.

Weinberg RB, Gallagher JW, Fabritius MA, Shelness GS. ApoA-IV modulates the secretory trafficking of apoB and the size of triglyceride-rich lipoproteins. J Lipid Res. 2012;53(4):736-743.

Weinberg RB. The watchman. Ann Intern Med. 2012;156(8):602-603.
 
Blade AM, Fabritius MA, Hou L, Weinberg RB, Shelness GS. Biogenesis of apolipoprotein A-V and its impact on VLDL triglyceride secretion. J Lipid Res. 2011; 52(2):237-244.
 
 
Ledford AS, Cook VA [sic] [Cook VR], Shelness GS, Weinberg RB. Structural and dynamic interfacial properties of the lipoprotein initiating domain of apolipoprotein B. J Lipid Res. 2009; 50(1):108-115.
 
Simon T, Weinberg RB. Intestinal apolipoprotein A-IV expression regionally modulates the number and size of secreted triglyceride-rich lipoproteins [abstract]. Arterioscler Thromb Vasc Biol. 2009; 29(7):e107.
 
Simon T, Cook VR, Rao A, Weinberg RB. ApoA-IV expression alters the proximal-distal gradient of intestinal triglyceride absorption efficiency [abstract]. Arterioscler Thromb Vasc Biol. 2008; 28(6):e-98.
 
McKimmie RL, Daniel KR, Carr JJ, Bowden DW, Freedman BI, Register TC, Hsu F-C, Lohman KK, Weinberg RB, Wagenknecht LE. Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: the Diabetes Heart Study. Am J Gastroenterol. 2008; 103(12):3029-3035.
 
Weinberg RB. An iodine fluorescence quenching clock reaction. J Chem Edu. 2007; 84(5):797-800.
 
Wong W-MR, Gerry AB, Putt W, Roberts JL, Weinberg RB, Humphries SE, Leake DS, Talmud PJ. Common variants of apolipoprotein A-IV differ in their ability to inhibit low density lipoprotein oxidation. Atherosclerosis. 2007; 192(2):266-274.
 
Beckstead JA, Wong K, Gupta V, Wan C-PL, Cook VR, Weinberg RB, Weers PMM, Ryan RO. The C terminus of apolipoprotein A-V modulates lipid-binding activity. J Biol Chem. 2007; 282(21):15484-89.
 
Beckstead JA, Wong K, Gupta V, Wan C-PL, Cook VR, Weinberg RB, Weers PM, Ryan RO. A C-terminal truncated human apolipoprotein A-V displays unique structural and lipid-binding properties [abstract]. Arterioscler Thromb Vasc Biol. 2007; 27(6):e-120.

 

atherosclerosis/thrombosis, diabetes, drugs/therapeutic agents pharm, ethics, hormones/cytokines/signalling, metabolism, nutrition